Cinoxacin

Cinoxacin (Compound 64716), a synthetic antimicrobial related to the quinolone class of orally active antibacterial agent. Cinoxacin has antibacterial activity against many gram-negative aerobic bacteria and inhibits bacterial DNA synthesis. Cinoxacin can be used for the research of urinary tract infections and bacterial prostatitis[1][2].

Product Specifications

CAS Number

[28657-80-9]

Product Name Alternative

Compound 64716

UNSPSC

12352005

Hazard Statement

H302, H315, H319, H335

Target

Antibiotic; Bacterial; DNA/RNA Synthesis

Type

Reference compound

Related Pathways

Anti-infection; Cell Cycle/DNA Damage

Applications

COVID-19-immunoregulation

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/Cinoxacin.html

Purity

99.99

Solubility

DMSO : 8.33 mg/mL (ultrasonic)

Smiles

O=C(C1=NN(CC)C2=C(C=C3C(OCO3)=C2)C1=O)O

Molecular Formula

C12H10N2O5

Molecular Weight

262.22

Precautions

H302, H315, H319, H335

References & Citations

[1]Scavone JM, et al. Cinoxacin: mechanism of action, spectrum of activity, pharmacokinetics, adverse reactions, and therapeutic indications. Pharmacotherapy. 1982 Sep-Oct;2 (5) :266-72. |[2]W E Wick, et al. Compound 64716, a new synthetic antibacterial agent. Antimicrob Agents Chemother. 1973 Oct;4 (4) :415-20.